{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:54:37Z","timestamp":1792061677024,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":1963,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chinese Medical Sciences Journal"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.24920\/003799","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T04:37:09Z","timestamp":1611031029000},"page":"377-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Trastuzumab-Induced Severe Thrombocytopenia: A Case Report and Literature Review"],"prefix":"10.1016","volume":"35","author":[{"given":"Xiaoqi","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.24920\/003799_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.24920\/003799_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40880-019-0368-6","article-title":"Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"10.24920\/003799_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.21147\/j.issn.1000-9604.2019.05.06","article-title":"Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer: A real-world retrospective study in Chinese patients","volume":"31","author":"Guo","year":"2019","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"10.24920\/003799_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMra043186","article-title":"Trastuzumab: mechanism of action and use in clinical practice","volume":"357","author":"Hudis","year":"2007","journal-title":"N Engl J Med"},{"issue":"10075","key":"10.24920\/003799_bib5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(16)32616-2","article-title":"11 years\u2019 follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial","volume":"389","author":"Cameron","year":"2017","journal-title":"The Lancet"},{"issue":"9","key":"10.24920\/003799_bib6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/annonc\/mdp370","article-title":"Severe drug-induced thrombocytopenia after treatment with trastuzumab but not with lapatinib","volume":"20","author":"Cathomas","year":"2009","journal-title":"Ann Oncol"},{"issue":"3","key":"10.24920\/003799_bib7","first-page":"285","article-title":"Severe thrombocytopenia induced by a single infusion of trastuzumab","volume":"8","author":"Parikh","year":"2008","journal-title":"Clin Br Cancer"},{"issue":"9","key":"10.24920\/003799_bib8","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/annonc\/mdp374","article-title":"Drug-induced thrombocytopenia induced by trastuzumab: a special challenge in a curable disease","volume":"20","author":"Jara Sanchez","year":"2009","journal-title":"Ann Oncol"},{"issue":"3","key":"10.24920\/003799_bib9","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/annonc\/mdp566","article-title":"Trastuzumab-related thrombocytopenia: always a self-limiting complication?","volume":"21","author":"Drudi","year":"2010","journal-title":"Ann Oncol"},{"issue":"7","key":"10.24920\/003799_bib10","doi-asserted-by":"crossref","first-page":"CS85","DOI":"10.12659\/MSM.881838","article-title":"Severe thrombocytopenia related to trastuzumab infusion","volume":"17","author":"Mantzourani","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.24920\/003799_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/1756-0500-6-400","article-title":"Severe thrombocytopenia after trastuzumab retreatment: a case report","volume":"6","author":"Pino","year":"2013","journal-title":"BMC Res Notes"},{"issue":"2","key":"10.24920\/003799_bib12","first-page":"e69","article-title":"Severe thrombocytopenia induced by second exposure to trastuzumab can be alleviated by prolonging the interval between treatments","volume":"14","author":"Zeng","year":"2014","journal-title":"Clin Br Cancer"},{"issue":"5","key":"10.24920\/003799_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/jcpt.12416","article-title":"Gradual thrombocytopenia induced by long-term trastuzumab exposure","volume":"41","author":"Miarons","year":"2016","journal-title":"J Clin Pharm Therapeut"},{"issue":"4","key":"10.24920\/003799_bib14","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1177\/000313481908500413","article-title":"Thrombocytopenia induced by herceptin","volume":"85","author":"Luo","year":"2019","journal-title":"Am Surg"},{"issue":"11","key":"10.24920\/003799_bib15","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009","article-title":"Drug-induced thrombocytopenia: a systematic review of published case reports","volume":"129","author":"George","year":"1998","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.24920\/003799_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra066469","article-title":"Drug-induced immune thrombocytopenia","volume":"357","author":"Aster","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"10.24920\/003799_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1538-7836.2009.03360.x","article-title":"Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management","volume":"7","author":"Aster","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"23","key":"10.24920\/003799_bib18","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"issue":"6","key":"10.24920\/003799_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12185-018-2445-z","article-title":"Chinese guidelines for treatment of adult primary immune thrombocytopenia","volume":"107","author":"Liu","year":"2018","journal-title":"Int J Hematol"}],"container-title":["Chinese Medical Sciences Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1001929421000134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1001929421000134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/cmsj.cams.cn\/previewFile?fileName=Trastuzumab-Induced%20Severe%20Thrombocytopenia%3AA%20Case%20Report%20and%20Literature%20Review&id=56560977&type=pdf&lang=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:32:57Z","timestamp":1792060377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1001929421000134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1001929421000134"],"URL":"https:\/\/doi.org\/10.24920\/003799","relation":{},"ISSN":["1001-9294"],"issn-type":[{"value":"1001-9294","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trastuzumab-Induced Severe Thrombocytopenia: A Case Report and Literature Review","name":"articletitle","label":"Article Title"},{"value":"Chinese Medical Sciences Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.24920\/003799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Chinese Academy Medical Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}